Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India Ltd | Sector: Pharmaceuticals | ISIN: INE051N01026

Trade

Corporate Actions

15 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2023

12:00 AM

Results

View Details

02 Nov , 2022

12:00 AM

Results

View Details

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Sep , 2022

12:00 AM

AGM

Announcement date: 13 Sep , 2022

View Details

07 Jul , 2022

12:00 AM

Results

View Details

07 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Mar , 2022

12:00 AM

Bonus

View Details

13 Sep , 2022

12:00 AM

BookCloser

View Details

Shree Ganesh Biotech India Ltd News and Update

Mr. Sanjay Kalirona, CEO and Co-founder, Gizmore

24 March, 2023 |
4:04 PM

Almost our entire smartwatch portfolio is now manufactured in India.

Coal Indian expected to supply 33 million tonnes of coal to non-power custo...

24 March, 2023 |
4:04 PM

Adani Power sells Support Properties Private Ltd to AdaniConnex

IIFL News Service |
24 March, 2023 |
4:03 PM

Bharti Airtel's 5G now in 500 cities of India

24 March, 2023 |
4:03 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	972.80	89.99	2,33,407.31	486.73	1.03	4,549.90	108.48
Divis Laboratories Ltd	2,809.00	31.40	74,497.12	310.90	1.07	1,689.83	454.85
Dr Reddys Laboratories Ltd	4,462.75	31.49	74,309.82	324.60	0.67	3,879.60	1,156.21
Cipla Ltd	877.00	25.58	70,787.11	678.52	0.57	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,517.75	48.99	51,379.40	229.00	1.58	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Shree Ganesh Biotech India Ltd

Kalpak Mahendrabhai Vadodaria
Non Executive Director

Varun Pravinchandra Aghara
Independent Director

Sombir Singh
Additional Director

Chandni Solanki
Independent Director

Kishan Nityanand Naidu
Additional Director

Manisha Maneklal Patel
Additional Director

Namita Acharya
Company Secretary

Summary

Summary Info Not Found

Reports by Shree Ganesh Biotech India Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Shree Ganesh Biotech India Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Shree Ganesh Biotech India Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 27 March , 2023 | 03:17 AM

Knowledge Center

Shree Ganesh Biotech India Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Shree Ganesh Biotech India Ltd

Kalpak Mahendrabhai Vadodaria

Varun Pravinchandra Aghara

Sombir Singh

Chandni Solanki

Kishan Nityanand Naidu

Manisha Maneklal Patel

Namita Acharya

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
27 March , 2023 | 03:17 AM